Physician

Adam Michael Falcone, M.D.

According to 2025 Medicare claims, Adam Falcone, M.D. (NPI: 1558534958) practices cardiology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is WACO CARDIOLOGY ASSOCIATES (NPI: 1982607735; TIN: 74-1784088) and primary practice location at 76712-4054. Falcone is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Falcone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,451 traditional Medicare patients, billed 5,067 HCPCS/CPT codes, and received $487,952 in Medicare payments. The top billing code was 99487 (Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month). Part D data shows 7,982 prescription claims across 1,058 beneficiaries totaling $1,113,550 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 21 records totaling $1,719. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $25,042 to $1,113,550. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,382	2,773	$115,432
2016	4,158	11,583	$437,944
2017	3,325	9,745	$437,534
2018	2,920	11,025	$615,127
2019	2,797	7,506	$556,569
2020	1,808	6,866	$473,860
2021	1,687	6,544	$538,113
2022	1,651	4,425	$436,964
2023	1,589	4,406	$478,755
2024	1,451	5,067	$487,952

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	227	744	$25,042
2016	719	6,144	$389,126
2017	867	8,205	$544,181
2018	1,163	8,963	$637,014
2019	1,126	8,570	$658,696
2020	1,069	8,383	$794,859
2021	1,063	7,827	$869,965
2022	1,011	7,590	$939,993
2023	967	7,254	$980,705
2024	1,058	7,982	$1,113,550

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99487	Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month	201	623	$103
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	302	302	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	727	948	$84
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	646	697	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	131	149	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	720	30,797	$575,077
Repatha Sureclick	Evolocumab	127	7,634	$142,383
Xarelto	Rivaroxaban	189	7,290	$130,771
Entresto	Sacubitril/Valsartan	96	3,720	$81,421
Praluent Pen	Alirocumab	32	1,402	$24,381

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$1,719	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Michael Falcone, M.D.?

Tedicare shows public-source Medicare data for Adam Michael Falcone, M.D. (NPI 1558534958), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Michael Falcone, M.D. have ACO affiliation data?

Adam Michael Falcone, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Adam Michael Falcone, M.D.?

Adam Michael Falcone, M.D. is linked to WACO CARDIOLOGY ASSOCIATES (billing NPI 1982607735) in the available physician profile data.

Does Adam Michael Falcone, M.D. have Open Payments data?

Adam Michael Falcone, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.